Catalyst Wire Dossier Catalyst Wire Dossier

F/TAF

emtricitabine/tenofovir alafenamide · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for F/TAF, covering 2016-11-30 to 2021-01-25. Get the full timeline:

Most recent: Clinical Trial Update: The Cellular Pharmacology of F-TAF in Dried Blood Spots [Phase 1]

See pricing